{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:31:16Z","timestamp":1792607476573,"version":"4.5.0"},"reference-count":53,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Sports Health: A Multidisciplinary Approach"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>With increased use of cannabis-based products by the public for both recreational and medical use, sports medicine clinicians should be informed of historical context, current legal considerations, and existing evidence with regard to efficacy, safety, and risks in the athletic community.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Evidence Acquisition:<\/jats:title>\n                    <jats:p>A review of ClinicalTrials.gov, MEDLINE, and CINAHL from 2015 to present was conducted with emphasis on the most recent literature using search terms, cannabis, nabiximols, cannabinoids, pain management, THC, CBD, and marijuana. Bibliographies based on original search were utilized to pursue further literature search.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design:<\/jats:title>\n                    <jats:p>Clinical review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>Level 3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>At present, limited high-quality studies exist for use of cannabinoids for acute pain, chronic pain, or concussion. None of the trials involving cannabinoids included the athletic population. Thus, results from this clinical review are extrapolated to conditions of the sports medicine population. For acute pain, 2 small-randomized double-blinded crossover trials concluded no immediate effect of cannabinoid therapy. More robust evidence exists for treatment of chronic pain conditions through meta-analysis and systemic reviews. Cannabinoid therapy exhibits moderate efficacy as a treatment for some chronic pain conditions. Investigations included a broad spectrum of chronic pain conditions, including neuropathic, musculoskeletal, inflammatory, and central pain conditions, and reveal reduction in pain and improvement of quality of life with limited adverse effects. For concussion, evidence is based on preclinical in vitro and animal models revealing possible neuroprotective effects as well as 2 clinical studies involving the presence of cannabinoids for concussion (some sports-related), but there are no high-quality trials evaluating efficacy for treatment with cannabinoids at this time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Although various biochemical explanations exist on the use of cannabinoid therapy through modulation of the endocannabinoid system for several medical issues affecting athletes, recommendations from clinicians must be extrapolated from a majority of research done in the nonathletic population. Lack of strong-quality clinical evidence, coupled with inconsistent federal and state law as well as purity issues with cannabis-based products, make it difficult for the sports medicine clinician to widely recommend cannabinoid therapeutics at present. Future larger, higher quality clinical research studies with standardized pure extracts will better guide appropriate medical use going forward. At present, evidence for a multitude of therapeutic applications is emerging for cannabinoid treatment approaches. With emphasis placed on patient-centered clinical decisions, cannabinoids hold promise of treatment for athletes with chronic pain conditions. Clinicians who treat the athletic community must consider legal and ethical issues when discussing and recommending the use of cannabinoids, with acknowledgment of inconsistencies in purity of various formulations and concerns of drug testing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1941738120956604","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T13:36:01Z","timestamp":1600263361000},"page":"540-546","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":17,"title":["Understanding Cannabis-Based Therapeutics in Sports Medicine"],"prefix":"10.1177","volume":"12","author":[{"given":"Gretchen E.","family":"Maurer","sequence":"first","affiliation":[{"name":"Lehigh Valley Health Network, Allentown, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neilson M.","family":"Mathews","sequence":"additional","affiliation":[{"name":"Lehigh Valley Health Network, Allentown, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin T.","family":"Schleich","sequence":"additional","affiliation":[{"name":"Carver College of Medicine, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler G.","family":"Slayman","sequence":"additional","affiliation":[{"name":"Carver College of Medicine, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt L.","family":"Marcussen","sequence":"additional","affiliation":[{"name":"Carver College of Medicine, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"key":"bibr1-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0775-9"},{"key":"bibr2-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2016.03.002"},{"key":"bibr3-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11909"},{"key":"bibr4-1941738120956604","doi-asserted-by":"crossref","unstructured":"Booz GW. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. 2011;51:1054-1061.","DOI":"10.1016\/j.freeradbiomed.2011.01.007"},{"key":"bibr5-1941738120956604","unstructured":"Consumer Reports. CBD is legal, but is it safe? Accessed October 28, 2019. https:\/\/www.consumerreports.org\/cbd\/cbd-may-be-legal-but-is-it-safe"},{"key":"bibr6-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2004.011718"},{"key":"bibr7-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(98)01283-1"},{"key":"bibr8-1941738120956604","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00403"},{"key":"bibr9-1941738120956604","unstructured":"Electronic Medicines Compendium. Nabiximols. Accessed October 30, 2019. https:\/\/www.medicines.org.uk\/emc\/product\/602"},{"key":"bibr10-1941738120956604","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2009.0034"},{"key":"bibr11-1941738120956604","unstructured":"ESPN. MLB, union agree to opioid testing; marijuana removed as \u201cdrug of abuse.\u201d Accessed May 6, 2020. https:\/\/www.espn.com\/mlb\/story\/_\/id\/28283499\/mlb-union-agree-opioid-testing-marijuana-removed-drug-abuse."},{"key":"bibr12-1941738120956604","unstructured":"Food and Drug Administration. FDA and cannabis: research and drug approval process. Accessed March 23, 2020. https:\/\/www.fda.gov\/news-events\/public-health-focus\/fda-and-cannabis-research-and-drug-approval-process"},{"key":"bibr13-1941738120956604","unstructured":"Food and Drug Administration. Regulation of cannabis and cannabis-derived products, including cannabidiol (CBD). Accessed December 6, 2019. https:\/\/www.fda.gov\/news-events\/public-health-focus\/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd"},{"key":"bibr14-1941738120956604","unstructured":"Food and Drug Administration. Warning letters and test results for cannabidiol-related products. Accessed December 20, 2019. https:\/\/www.fda.gov\/news-events\/public-health-focus\/warning-letters-and-test-results-cannabidiol-related-products."},{"key":"bibr15-1941738120956604","unstructured":"Food and Drug Administration. What you need to know (and what we\u2019re working to find out) about products containing cannabis or cannabis-derived compounds, including CBD. 2019. Accessed December 30, 2019. https:\/\/www.fda.gov\/consumers\/consumer-updates\/what-you-need-know-and-what-were-working-find-out-about-products-containing-cannabis-or-cannabis"},{"key":"bibr16-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1007\/s40279-014-0260-0"},{"key":"bibr17-1941738120956604","unstructured":"GW Pharmaceuticals. Sativex for healthcare professionals. Accessed December 15, 2019. https:\/\/www.gwpharm.com\/healthcare-professionals\/sativex"},{"key":"bibr18-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1007\/s40279-015-0387-7"},{"key":"bibr19-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31817881e1"},{"key":"bibr20-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2019-100590"},{"key":"bibr21-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000260"},{"key":"bibr22-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13250"},{"key":"bibr23-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1080\/02699052.2019.1679885"},{"key":"bibr24-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03970.x"},{"key":"bibr25-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.01.004"},{"key":"bibr26-1941738120956604","unstructured":"Major League Baseball. Majour League Baseball\u2019s Joint Drug Prevention and Treatment Program. Accessed January 9, 2020. http:\/\/mlb.mlb.com\/pa\/pdf\/jda.pdf"},{"key":"bibr27-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14204"},{"key":"bibr28-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12944"},{"key":"bibr29-1941738120956604","volume-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","author":"National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"key":"bibr30-1941738120956604","unstructured":"National Basketball Association. CBA 101. Highlights of the collective bargaining agreement between the National Basketball Association (NBA) and the National Basketball Players Association (NBPA). Accessed January 9, 2020. https:\/\/cdn.nba.net\/nba-drupal-prod\/2018-19CBA.pdf"},{"key":"bibr31-1941738120956604","unstructured":"National Collegiate Athletic Association. NCAA increases THC testing threshold. June 20, 2019. Accessed May 14, 2020. http:\/\/www.ncaa.org\/about\/resources\/media-center\/news\/ncaa-increases-thc-testing-threshold"},{"key":"bibr32-1941738120956604","unstructured":"National Conference of State Legislatures. State medical marijuana laws. Accessed October 1, 2019. http:\/\/www.ncsl.org\/research\/health\/state-medical-marijuana-laws.aspx"},{"key":"bibr33-1941738120956604","unstructured":"National Football League. Policy and program on substances of abuse 2020. Accessed May 14, 2020. https:\/\/nflpaweb.blob.core.windows.net\/website\/2020-Policy-and-Program-on-Substances-of-Abuse.pdf"},{"key":"bibr34-1941738120956604","unstructured":"National Hockey League. NHL-NHLPA team up against performance-enhancing substances. Accessed January 9, 2020. http:\/\/www.nhl.com\/ice\/page.htm?id=26397"},{"key":"bibr35-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1177\/000313481408001015"},{"key":"bibr36-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.51"},{"key":"bibr37-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1038\/35097089"},{"key":"bibr38-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707442"},{"key":"bibr39-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2017.03.004"},{"key":"bibr40-1941738120956604","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00069"},{"key":"bibr41-1941738120956604","unstructured":"United States Anti-Doping Agency. Athletes: 6 things to know about cannabidiol. Accessed October 28, 2019. https:\/\/www.usada.org\/spirit-of-sport\/education\/six-things-know-about-cannabidiol"},{"key":"bibr42-1941738120956604","unstructured":"United States Anti-Doping Agency. US triathlon athlete Lauren Goss accepts sanction for anti-doping rule violation. Accessed September 5, 2019. https:\/\/www.usada.org\/sanction\/lauren-goss-accepts-doping-sanction"},{"key":"bibr43-1941738120956604","unstructured":"United States Congress. S.4325. 103rd Congress: Dietary Supplement Health and Education Act of 1994. Public Law 103-417, October 25, 1994."},{"key":"bibr44-1941738120956604","unstructured":"United States Department of Agriculture. Farm Bill 2018. Accessed October 9, 2019. https:\/\/nifa.usda.gov\/industrial-hemp"},{"key":"bibr45-1941738120956604","unstructured":"United States Food and Drug Administration. Cesamet (nabilone) capsules. NDA 18-677\/S-011. 2006:3. Accessed October 15, 2019. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2006\/018677s011lbl.pdf"},{"key":"bibr46-1941738120956604","unstructured":"United States Food and Drug Administration. Epidiolex\u00ae (cannabidiol) [package insert]. Greenwich Biosciences Inc; 2018. Accepted October 15, 2019. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210365lbl.pdf"},{"key":"bibr47-1941738120956604","unstructured":"United States Food and Drug Administration. Marinol (dronabinol) capsules. NDA 18-651\/S-021. Accessed October 15, 2019. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/018651s029lbl.pdf"},{"key":"bibr48-1941738120956604","unstructured":"World Anti-Doping Aagency. Prohibited list documents. Accessed October 28, 2019. https:\/\/www.wada-ama.org\/en\/resources\/science-medicine\/prohibited-list-documents"},{"key":"bibr49-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000286986.92475.b7"},{"key":"bibr50-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1097\/JSM.0000000000000650"},{"key":"bibr51-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2018.10.001"},{"key":"bibr52-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.6358"},{"key":"bibr53-1941738120956604","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218998"}],"container-title":["Sports Health: A Multidisciplinary Approach"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1941738120956604","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1941738120956604","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1941738120956604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:44:15Z","timestamp":1777589055000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1941738120956604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1177\/1941738120956604"],"URL":"https:\/\/doi.org\/10.1177\/1941738120956604","relation":{},"ISSN":["1941-7381","1941-0921"],"issn-type":[{"value":"1941-7381","type":"print"},{"value":"1941-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,16]]}}}